Clinical trials
Phase 1 Tuberculosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
160 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 4 |
| 2007 | 9 |
| 2008 | 12 |
| 2009 | 10 |
| 2010 | 12 |
| 2011 | 5 |
| 2012 | 7 |
| 2013 | 8 |
| 2014 | 3 |
| 2015 | 12 |
| 2016 | 7 |
| 2017 | 10 |
| 2018 | 5 |
| 2019 | 5 |
| 2020 | 8 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 5 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 131 |
| Unknown status | 8 |
| Terminated | 7 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Not yet recruiting | 3 |
| Withdrawn | 3 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Oxford | 27 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 20 |
| Global Alliance for TB Drug Development | 14 |
| Aeras | 12 |
| Statens Serum Institut | 7 |
| Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 6 |
| GlaxoSmithKline | 6 |
| National University Hospital, Singapore | 5 |
| Sequella, Inc. | 3 |
| Tibotec BVBA | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tuberculosis | 160 |
| Tuberculosis, Pulmonary | 17 |
| HIV Infections | 9 |
| Acquired Immunodeficiency Syndrome | 5 |
| Tuberculosis, Multidrug-Resistant | 5 |
| Lung Diseases | 4 |
| Mycobacterium Infections | 4 |
| AIDS-Related Opportunistic Infections | 3 |
| Adenoviridae Infections | 2 |
| Bacterial Infections | 2 |
Trials
Showing 76 to 100 of 160. Each trial links to its page on Pharma Observatory.
60 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.